menu
    • menu

    Company profile for Aptorum

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The pipeline of Aptorum is also enriched through (i) the establishment of drug discovery platforms that enabl...
    Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The pipeline of Aptorum is also enriched through (i) the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g. systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aptorumunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    17 Hanover Square, London W1S 1BN
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aptorumgroup.com/index
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aptorum-group-limited/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aptorumg

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptorum Group Reports Financials & Update for 6 Months Ended Jun 30
    Aptorum Group Reports Financials & Update for 6 Months Ended Jun 30

    20 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241220907803/en

    BUSINESSWIRE
    20 Dec 2024
    Share Share
    Aptorum FY 2023 Results and Business Update
    Aptorum FY 2023 Results and Business Update

    30 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240424559376/en

    BUSINESSWIRE
    30 Apr 2024
    Share Share
    Aptorum Announces Entering into an Agreement and Plan of Merger with YOOV
    Aptorum Announces Entering into an Agreement and Plan of Merger with YOOV

    06 Mar 2024

    // PRESS RELEASE

    https://ir.aptorumgroup.com/news-releases/news-release-details/aptorum-group-ltd-announces-entering-agreement-and-plan-merger

    PRESS RELEASE
    06 Mar 2024
    Share Share
    Aptorum Group Limited Reports Financial Results
    Aptorum Group Limited Reports Financial Results

    22 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231221632368/en

    BUSINESSWIRE
    22 Dec 2023
    Share Share
    Aptorum Announces Results of 2023 Annual General Meeting of Shareholders
    Aptorum Announces Results of 2023 Annual General Meeting of Shareholders

    21 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231221861401/en

    BUSINESSWIRE
    21 Dec 2023
    Share Share
    Aptorumto Hold Annual General Meeting of Shareholders on December 20, 2023
    Aptorumto Hold Annual General Meeting of Shareholders on December 20, 2023

    16 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231115679564/en

    BUSINESSWIRE
    16 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search